235 related articles for article (PubMed ID: 17134739)
21. Cyclin D1 and t(11;14)-positive B-cell neoplasms resembling marginal zone B-cell lymphoma: a morphological variant of mantle cell lymphoma.
Mansoor A; Akbari M; Auer I; Lai R
Hum Pathol; 2007 May; 38(5):797-802. PubMed ID: 17316759
[TBL] [Abstract][Full Text] [Related]
22. The morphologic spectrum of non-Hodgkin's lymphomas with BCL1/cyclin D1 gene rearrangements.
Swerdlow SH; Zukerberg LR; Yang WI; Harris NL; Williams ME
Am J Surg Pathol; 1996 May; 20(5):627-40. PubMed ID: 8619427
[TBL] [Abstract][Full Text] [Related]
23. "In situ-like" mantle cell lymphoma: a report of two cases.
Richard P; Vassallo J; Valmary S; Missoury R; Delsol G; Brousset P
J Clin Pathol; 2006 Sep; 59(9):995-6. PubMed ID: 16935977
[TBL] [Abstract][Full Text] [Related]
24. Small B-cell neoplasms with typical mantle cell lymphoma immunophenotypes often include chronic lymphocytic leukemias.
Ho AK; Hill S; Preobrazhensky SN; Miller ME; Chen Z; Bahler DW
Am J Clin Pathol; 2009 Jan; 131(1):27-32. PubMed ID: 19095562
[TBL] [Abstract][Full Text] [Related]
25. The cellular origin of mantle cell lymphoma.
Bertoni F; Ponzoni M
Int J Biochem Cell Biol; 2007; 39(10):1747-53. PubMed ID: 17574898
[TBL] [Abstract][Full Text] [Related]
26. CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma of ocular adnexal origin: usefulness of fluorescence in situ hybridization for distinction between mantle cell lymphoma and MALT lymphoma.
Tasaki K; Shichishima A; Furuta M; Yoshida S; Nakamura N; Abe M
Pathol Int; 2007 Feb; 57(2):101-7. PubMed ID: 17300675
[TBL] [Abstract][Full Text] [Related]
27. Primary splenic marginal zone lymphoma with florid granulomatous reaction--a case report and review of literature.
Manipadam MT; Viswabandya A; Srivastava A
Pathol Res Pract; 2007; 203(4):239-43. PubMed ID: 17398014
[TBL] [Abstract][Full Text] [Related]
28. Combined molecular diagnosis of B-cell lymphomas with t(11;14)(q13;q32) or t(14;18)(q32;q21) using multiplex- and long distance inverse-polymerase chain reaction.
Vieira L; Martinho A; Antunes O; Silva E; Ambrósio AP; Geraldes MC; Nascimento R; Silva C; Pereira JM; Júnior EC; Jordan P
Diagn Mol Pathol; 2008 Jun; 17(2):73-81. PubMed ID: 18382373
[TBL] [Abstract][Full Text] [Related]
29. A 3-way collision tumor of the upper respiratory tract: a composite of 2 immunophenotypically distinct mantle cell lymphomas and a plasmacytoma.
Wang HY; Karandikar N; Payne D; Maleki A; Schultz BA; Collins R; McKenna RW
Hum Pathol; 2008 May; 39(5):781-7. PubMed ID: 18284935
[TBL] [Abstract][Full Text] [Related]
30. Relevance of a scoring system including CD11c expression in the identification of splenic diffuse red pulp small B-cell lymphoma (SRPL).
Baseggio L; Traverse-Glehen A; Callet-Bauchu E; Morel D; Magaud JP; Berger F; Salles G; Felman P
Hematol Oncol; 2011 Mar; 29(1):47-51. PubMed ID: 20677173
[TBL] [Abstract][Full Text] [Related]
31. An unusual case of leukemic mantle cell lymphoma with a blastoid component showing loss of CD5 and aberrant expression of CD10.
Morice WG; Hodnefield JM; Kurtin PJ; Hanson CA
Am J Clin Pathol; 2004 Jul; 122(1):122-7. PubMed ID: 15272540
[TBL] [Abstract][Full Text] [Related]
32. Nodal and splenic marginal zone B cell lymphomas.
Mollejo M; Camacho FI; Algara P; Ruiz-Ballesteros E; García JF; Piris MA
Hematol Oncol; 2005; 23(3-4):108-18. PubMed ID: 16307458
[TBL] [Abstract][Full Text] [Related]
33. Recurrent genomic imbalances in B-cell splenic marginal-zone lymphoma revealed by comparative genomic hybridization.
Andersen CL; Gruszka-Westwood A; Atkinson S; Matutes E; Catovsky D; Pedersen RK; Pedersen BB; Pulczynski S; Hokland P; Jacobsen E; Koch J
Cancer Genet Cytogenet; 2005 Jan; 156(2):122-8. PubMed ID: 15642391
[TBL] [Abstract][Full Text] [Related]
34. Primary cutaneous blastoid mantle cell lymphoma-case report.
Estrozi B; Sanches JA; Varela PC; Bacchi CE
Am J Dermatopathol; 2009 Jun; 31(4):398-400. PubMed ID: 19461249
[TBL] [Abstract][Full Text] [Related]
35. Coexistence of BCL1/CCND1 and CMYC aberrations in blastoid mantle cell lymphoma: a rare finding associated with very poor outcome.
Michaux L; Wlodarska I; Theate I; Stul M; Scheiff JM; Deneys V; Ferrant A; Hagemeijer A
Ann Hematol; 2004 Sep; 83(9):578-83. PubMed ID: 15138714
[TBL] [Abstract][Full Text] [Related]
36. Variant t(2;11)(p11.2;q13) without IGK involvement in a case of mantle cell lymphoma.
Woroniecka R; Grygalewicz B; Pienkowska-Grela B; Rymkiewicz G; Konecki R; Swoboda P; Janik P
Cancer Genet Cytogenet; 2007 Jun; 175(2):154-8. PubMed ID: 17556072
[TBL] [Abstract][Full Text] [Related]
37. Splenic marginal zone lymphoma.
Oscier D; Owen R; Johnson S
Blood Rev; 2005 Jan; 19(1):39-51. PubMed ID: 15572216
[TBL] [Abstract][Full Text] [Related]
38. Splenic marginal-zone lymphoma: one or more entities? A histologic, immunohistochemical, and molecular study of 42 cases.
Papadaki T; Stamatopoulos K; Belessi C; Pouliou E; Parasi A; Douka V; Laoutaris N; Fassas A; Anagnostopoulos A; Anagnostou D
Am J Surg Pathol; 2007 Mar; 31(3):438-46. PubMed ID: 17325486
[TBL] [Abstract][Full Text] [Related]
39. Analysis of VH genes in marginal zone lymphoma reveals marked heterogeneity between splenic and nodal tumors and suggests the existence of clonal selection.
Traverse-Glehen A; Davi F; Ben Simon E; Callet-Bauchu E; Felman P; Baseggio L; Gazzo S; Thieblemont C; Charlot C; Coiffier B; Berger F; Salles G
Haematologica; 2005 Apr; 90(4):470-8. PubMed ID: 15820942
[TBL] [Abstract][Full Text] [Related]
40. CD27 distinguishes two phases in bone marrow infiltration of splenic marginal zone lymphoma.
Franco V; Florena AM; Ascani S; Paulli M; Salvato M; Pileri SA
Histopathology; 2004 Apr; 44(4):381-6. PubMed ID: 15049905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
